PTC Therapeutics, Inc.

ISIN US69366J2006

 | 

WKN A1W0MW

Marktkapitalisatie (in EUR)
4,998 m
Land
United States
Sector
Healthcare
Dividendrendement
0.00%
 

Overzicht

Beschrijving

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.
Toon meer Toon minder
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Financiële kerngegevens

Kerncijfers

Marktkapitalisatie, EUR 4,998 m
WPA, EUR 7.75
KBV -
K/W 8.7
Dividendrendement 0.00%

Income statement (2024)

Omzet, EUR 746 m
Netto-inkomen, EUR -336 m
Winstmarge -45.03%

What ETF is PTC Therapeutics, Inc. in?

There are 5 ETFs which contain PTC Therapeutics, Inc.. All of these ETFs are listed in the table below. The ETF with the largest weighting of PTC Therapeutics, Inc. is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weging Investeringsfocus Fondsgrootte (in m EUR)
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0.54%
Equity
United States
Health Care
Biotech
46
iShares S&P SmallCap 600 UCITS ETF 0.41%
Equity
United States
Small Cap
2,169
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.01%
Equity
World
Social/Environmental
491
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.01%
Equity
North America
Social/Environmental
24
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.10%
Equity
United States
Small Cap
190
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.